Who invested in AvengeBio?
AvengeBio's investors include Perceptive Advisors and Longitude Capital.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$45Mraised across 1 round since 2022, from 1 source
AvengeBio's investors include Perceptive Advisors and Longitude Capital.
AvengeBio has raised $45M across 1 round since 2022.
AvengeBio's most recent round was a Series A of $45M in Jan 2022.
Its most recent round, $45M in Jan 2022, is also its largest on record.
AvengeBio's first round on record, in Jan 2022, was backed by Perceptive Advisors and Longitude Capital.
AvengeBio's latest named round is a Series A, in Jan 2022.
AvengeBio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.